Zobrazeno 1 - 3
of 3
pro vyhledávání: '"HemaNandini Rajendran Krishnamoorthy"'
Publikováno v:
Vaccines, Vol 11, Iss 3, p 577 (2023)
Immunotherapy is emerging as a potential therapeutic strategy for triple negative breast cancer (TNBC) owing to the immunogenic landscape of its tumor microenvironment. Interestingly, peptide-based cancer vaccines have garnered a lot of attention as
Externí odkaz:
https://doaj.org/article/64d0d36703af4247936be8dc3e6ca214
Autor:
Bharath Sai Gandhamaneni, HemaNandini Rajendran Krishnamoorthy, Shanthi Veerappapillai, Soumya R. Mohapatra, Ramanathan Karuppasamy
Publikováno v:
Glycoconjugate Journal. 39:711-724
The Human Betaherpesviruses HHV-5 and HHV-6 are quite inimical in immunocompromised hosts individually. A co-infection of both has been surmised to be far more disastrous. This can be attributed to a synergetic effect of their combined pathologies. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594ed244ed059eda987f2d23854cc5f8
https://doi.org/10.1007/s10719-022-10083-7
https://doi.org/10.1007/s10719-022-10083-7
Publikováno v:
Molecular diversity.
Immunotherapies are a promising treatment option especially for the management of TNBC owing to its higher levels of tumour-associated antigens together with higher mutational load. Of note, the administration of preventive vaccines in the early stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012c773c796632a2c9e316ce51f2bf3d
https://pubmed.ncbi.nlm.nih.gov/36214961
https://pubmed.ncbi.nlm.nih.gov/36214961